TubeRank

Ticker archive

What was said about Moderna

This is the TubeRank file on MRNA. Price calls from finance YouTube are kept here with the original quote, then checked against the market once their window closes. Read it the way you would a research notebook.

MRNAModerna

$182.56as of 10h ago

The record, in brief

1 call from 1 channel is on file for MRNA. It has not resolved yet, so there is no hit rate to report. None are still pending. The record leans bullish: 1 bullish and 0 bearish.

On file
1

recorded call

Hit rate

nothing resolved yet

Pending
0

none waiting

Channels
1

1 bullish · 0 bearish

No chart in this file yet

Plotting needs at least two calls that each have a price target and a video date. What we do have is listed below.

Calls, by channel

Grouped by who said it. The latest thesis is written out; open a channel for the calls we kept, newest first.

Randy Kirk1 callBullish

The hosts discuss Moderna's mRNA cancer treatment breakthrough that reduced high-risk cancer recurrence, noting the stock roughly doubled to tripled on the news. They frame this as the start of a broader 'ChatGPT moment' for AI applied to medicine that could pull in massive R&D investment from big pharma.

Most recent thesisAug 20, 2026Source video

The hosts discuss Moderna's mRNA cancer treatment breakthrough that reduced high-risk cancer recurrence, noting the stock roughly doubled to tripled on the news. They frame this as the start of a broader 'ChatGPT moment' for AI applied to medicine that could pull in massive R&D investment from big pharma.